Type 2 Diabetes Mellitus and Hypertension

Lastra, Guido, Syed, Sofia, Kurukulasuriya, L. Romayne, Manrique, Camila, Sowers, James R.·2014·Endocrinology and Metabolism Clinics of North America
DOI 10.1016/j.ecl.2013.09.005

Cited by (307)

Items 301–307 of 307

  1. Large-scale genomic investigation into factors contributing to metabolic derangements and their comorbidity
    Vincent Pascat · 2024 · theses.fr (ABES)
  2. A realist review to understand the complexity of effective management of type 2 diabetes and hypertension
    Fatemeh Ehteshami, Anna Verjans, Rachel Cassidy, Fabrizio Tediosi, Günther Fink, Daniel Cobos Munoz · 2026 · Public health reviews
  3. Prevalence and Clinical Correlates of Orthostatic Hypertension and Hypotension in Diabetic Patients: A Facility based observational study from Kharagpur, India
    Arijita Banerjee, Shirin Dasgupta · 2026 · Preventive Medicine Research & Reviews
  4. Reliability and device objectivity in oscillatory blood pressure measurement – a measurement error analysis to inform clinical decision making
    Konstantin Warneke, Niklas Lebelt, Franz Liebermann, Benjamin Jöst, Marco Herbsleb · 2026 · BMC Cardiovascular Disorders
  5. Cardiometabolic Multimorbidity and Sympathetic Overactivity
    Wanjin Zhao, Yizhe Wu, Meng Ji, Li Shen, Zhaoqiang Cui, Chaosheng Wang, Zhifeng Yao, Juying Qian, Junbo Ge · 2026 · JACC Asia
  6. Cardiovascular effects of incretin receptor agonists: beyond glycemic control
    Marko P. Ravić, Ivan M. Srejovic, Isidora Milosavljević, Jovana N. Novakovic, Vladimir Jakovljević, Ksenija Vučićević, Djurdjina Petrovic, Maja D. Muric · 2026 · Canadian Journal of Physiology and Pharmacology
  7. Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes
    MD Kulvinder Kochar Kaur, DNB Gautam Allahbadia MD, DM Mandeep Singh MD · 2025 · Obesity Research - Open Journal